William Febbo | Chief Executive Officer |
Doug Baker | Chief Financial Officer |
Stephen Silvestro | Chief Commercial Officer |
Miriam Paramore | President |
Andrew D'Silva | B. Riley FBR, Inc. |
Ryan Daniels | William Blair & Company, L.L.C. |
Richard Baldry | ROTH Capital Partners, LLC |
Eric Martinuzzi | Lake Street Capital Markets, LLC |
Josh Goldberg | G2 Investment Partners |
Harvey Poppel | Poptech, LP |
Good afternoon, and thank you for joining us today to discuss OptimizeRx Corporation's Third Quarter ended September 30, 2020. With us today are the Company's Chief Executive Officer, William Febbo; Company President, Miriam Paramore; Chief Financial Officer, Doug Baker; and Chief Commercial Officer, Stephen Silvestro.
Following management's remarks today, we'll open the call to questions. And before we conclude the call today, I'll provide some important cautions regarding the forward-looking statements made by management during the call. I'd like to remind everyone that today's call is being recorded and will be made available for telephone replay via instructions in today's press release in the Investors section of the company's website.